Thomas Brick1, Rachel S Agbeko2, Patrick Davies3, Peter J Davis4, Akash Deep5, Peter-Marc Fortune6, David P Inwald7, Amy Jones8, Richard Levin9, Kevin P Morris10, John Pappachan11, Samiran Ray12, Shane M Tibby13, Lyvonne N Tume14, Mark J Peters8,12. 1. Paediatric Intensive Care Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK. thomas.brick@gmail.com. 2. Paediatric Intensive Care Unit, Great North Children's Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Institute of Cellular Medicine, Newcastle University, Newcastle, UK. 3. Paediatric Intensive Care Unit, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK. 4. Paediatric Intensive Care Unit, Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK. 5. Paediatric Intensive Care Unit, King's College Hospital NHS Foundation Trust, London, UK. 6. Paediatric Intensive Care Unit, Royal Manchester Children's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. 7. Paediatric Intensive Care Unit, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK. 8. Paediatric Intensive Care Unit, Great Ormond Street Hospital NHS Foundation Trust, London, UK. 9. Paediatric Intensive Care Unit, Royal Hospital for Children, Glasgow, UK. 10. Paediatric Intensive Care Unit, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. 11. Paediatric Intensive Care Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. 12. Respiratory, Critical Care and Anaesthesia Unit, University College London Institute of Child Health, London, UK. 13. Paediatric Intensive Care Unit, Evelina Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK. 14. School of Health, University of Central Lancashire, Lancashire, UK.
Abstract
The role played by fever in the outcome of critical illness in children is unclear. This survey of medical and nursing staff in 35 paediatric intensive care units and transport teams in the United Kingdom and Ireland established attitudes towards the management of children with fever. Four hundred sixty-two medical and nursing staff responded to a web-based survey request. Respondents answered eight questions regarding thresholds for temperature control in usual clinical practice, indications for paracetamol use, and readiness to participate in a clinical trial of permissive temperature control. The median reported threshold for treating fever in clinical practice was 38 °C (IQR 38-38.5 °C). Paracetamol was reported to be used as an analgesic and antipyretic but also for non-specific comfort indications. There was a widespread support for a clinical trial of a permissive versus a conservative approach to fever in paediatric intensive care units. Within a trial, 58% of the respondents considered a temperature of 39 °C acceptable without treatment. CONCLUSIONS: Staff on paediatric intensive care units in the United Kingdom and Ireland tends to treat temperatures within the febrile range. There was a willingness to conduct a randomized controlled trial of treatment of fever. What is known: • The effect of fever on the outcome in paediatric critical illness is unknown. • Paediatricians have traditionally been reluctant to allow fever in sick children. What is new: • Paediatric intensive care staff report a tendency towards treating fever, with a median reported treatment threshold of 38 °C. • There is widespread support amongst PICU staff in the UK for a randomized controlled trial of temperature in critically ill children. • Within a trial setting, PICU staff attitudes to fever are more permissive than in clinical practice.
The role played by fever in the outcome of critical illness in children is unclear. This survey of medical and nursing staff in 35 paediatric intensive care units and transport teams in the United Kingdom and Ireland established attitudes towards the management of children with fever. Four hundred sixty-two medical and nursing staff responded to a web-based survey request. Respondents answered eight questions regarding thresholds for temperature control in usual clinical practice, indications for paracetamol use, and readiness to participate in a clinical trial of permissive temperature control. The median reported threshold for treating fever in clinical practice was 38 °C (IQR 38-38.5 °C). Paracetamol was reported to be used as an analgesic and antipyretic but also for non-specific comfort indications. There was a widespread support for a clinical trial of a permissive versus a conservative approach to fever in paediatric intensive care units. Within a trial, 58% of the respondents considered a temperature of 39 °C acceptable without treatment. CONCLUSIONS: Staff on paediatric intensive care units in the United Kingdom and Ireland tends to treat temperatures within the febrile range. There was a willingness to conduct a randomized controlled trial of treatment of fever. What is known: • The effect of fever on the outcome in paediatric critical illness is unknown. • Paediatricians have traditionally been reluctant to allow fever in sick children. What is new: • Paediatric intensive care staff report a tendency towards treating fever, with a median reported treatment threshold of 38 °C. • There is widespread support amongst PICU staff in the UK for a randomized controlled trial of temperature in critically ill children. • Within a trial setting, PICU staff attitudes to fever are more permissive than in clinical practice.
Entities:
Keywords:
Acetaminophen; Attitudes to fever; Fever; Medical practises; Nursing practises; Paediatric intensive care; Paracetamol
Authors: Paul Jeffrey Young; Manoj Saxena; Richard Beasley; Rinaldo Bellomo; Michael Bailey; David Pilcher; Simon Finfer; David Harrison; John Myburgh; Kathryn Rowan Journal: Intensive Care Med Date: 2012-01-31 Impact factor: 17.440
Authors: Paul Young; Manoj Saxena; Rinaldo Bellomo; Ross Freebairn; Naomi Hammond; Frank van Haren; Mark Holliday; Seton Henderson; Diane Mackle; Colin McArthur; Shay McGuinness; John Myburgh; Mark Weatherall; Steve Webb; Richard Beasley Journal: N Engl J Med Date: 2015-10-05 Impact factor: 91.245
Authors: G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell Journal: N Engl J Med Date: 1997-03-27 Impact factor: 91.245
Authors: Roman Prymula; Claire-Anne Siegrist; Roman Chlibek; Helena Zemlickova; Marie Vackova; Jan Smetana; Patricia Lommel; Eva Kaliskova; Dorota Borys; Lode Schuerman Journal: Lancet Date: 2009-10-17 Impact factor: 79.321
Authors: Mark J Peters; Kerry Woolfall; Imran Khan; Elisabeth Deja; Paul R Mouncey; Jerome Wulff; Alexina Mason; Rachel S Agbeko; Elizabeth S Draper; Blaise Fenn; Doug W Gould; Abby Koelewyn; Nigel Klein; Christine Mackerness; Sian Martin; Lauran O'Neill; Samiran Ray; Padmanabhan Ramnarayan; Shane Tibby; Kentigern Thorburn; Lyvonne Tume; Jason Watkins; Paul Wellman; David A Harrison; Kathryn M Rowan Journal: Crit Care Date: 2019-03-07 Impact factor: 9.097